What is the current valuation of the UK Morphine Market?

As of 2024, the UK Morphine Market was valued at 0.648 USD Billion. Read More

What is the projected market size for the UK Morphine Market by 2035?

The market is projected to reach 1.29 USD Billion by 2035. Read More

What is the expected CAGR for the UK Morphine Market during the forecast period?

The expected CAGR for the UK Morphine Market from 2025 to 2035 is 6.5%. Read More

What are the main applications of morphine in the UK market?

The main applications include Pain Management, Palliative Care, Anesthesia, and Cough Suppression. Read More

How does the Pain Management segment perform in the UK Morphine Market?

The Pain Management segment was valued at 0.648 USD Billion in 2024 and is expected to grow significantly. Read More

What are the different formulations of morphine available in the UK?

Morphine is available in various formulations, including Injectable, Oral, Transdermal, and Sustained Release. Read More

Who are the primary end users of morphine in the UK?

Primary end users include Hospitals, Clinics, Home Care Settings, and Research Institutions. Read More

What is the projected growth trend for the Palliative Care segment in the UK Morphine Market?

The Palliative Care segment was valued at 0.162 USD Billion in 2024 and is anticipated to experience growth through 2035. Read More

UK Morphine Market

Q: Which companies are the key players in the UK Morphine Market?

Key players include Mundipharma, Purdue Pharma, Teva UK, Napp Pharmaceuticals, Boehringer Ingelheim, AstraZeneca, Sandoz, and AbbVie. Read More

Q: What distribution channels are utilized for morphine in the UK?

Distribution channels include Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, and Specialty Pharmacies. Read More

ID: MRFR/HC/49737-HCR

200 Pages

Vikita Thakur

Last Updated: March 28, 2026

UK Morphine Market Research Report: By Dosage Form (Injection, Oral, Other Dosage Forms), By Application (Pain Management, Diarrhea Suppressant, Cold & Cough Suppressant, Others), By Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies, Others) andBy End User (Hospitals & Clinics, Ambulatory Surgical Centers, Others)- Forecast to 2035

UK Morphine Market

Market Size

Forecast Period2025 - 2035

CAGR (2025 - 2035)6.5%

2018 Market Size$ 607.5 Million

2024 Market Size$ 0.65 Billion

2035 Market Size$ 1.29 Billion

Key Players

Mundipharma

Purdue Pharma

Teva UK

Napp Pharmaceuticals

Boehringer Ingelheim

AstraZeneca

Trends

Regulatory Developments
Technological Advancements
Changing Patient Demographics

Opportunities

Rising Incidence of Chronic Pain
Regulatory Framework Enhancements
Increased Focus on Palliative Care

Summary Table of Contents Segmentation Download PDF

Certified Researchers

Customize Report

1 SECTION I: EXECUTIVE SUMMARY AND KEY HIGHLIGHTS
1. 1.1 EXECUTIVE SUMMARY
  1. 1.1.1 Market Overview
  2. 1.1.2 Key Findings
  3. 1.1.3 Market Segmentation
  4. 1.1.4 Competitive Landscape
  5. 1.1.5 Challenges and Opportunities
  6. 1.1.6 Future Outlook
2 SECTION II: SCOPING, METHODOLOGY AND MARKET STRUCTURE
1. 2.1 MARKET INTRODUCTION
  1. 2.1.1 Definition
  2. 2.1.2 Scope of the study
    1. 2.1.2.1 Research Objective
    2. 2.1.2.2 Assumption
    3. 2.1.2.3 Limitations
2. 2.2 RESEARCH METHODOLOGY
  1. 2.2.1 Overview
  2. 2.2.2 Data Mining
  3. 2.2.3 Secondary Research
  4. 2.2.4 Primary Research
    1. 2.2.4.1 Primary Interviews and Information Gathering Process
    2. 2.2.4.2 Breakdown of Primary Respondents
  5. 2.2.5 Forecasting Model
  6. 2.2.6 Market Size Estimation
    1. 2.2.6.1 Bottom-Up Approach
    2. 2.2.6.2 Top-Down Approach
  7. 2.2.7 Data Triangulation
  8. 2.2.8 Validation
3 SECTION III: QUALITATIVE ANALYSIS
1. 3.1 MARKET DYNAMICS
  1. 3.1.1 Overview
  2. 3.1.2 Drivers
  3. 3.1.3 Restraints
  4. 3.1.4 Opportunities
2. 3.2 MARKET FACTOR ANALYSIS
  1. 3.2.1 Value chain Analysis
  2. 3.2.2 Porter's Five Forces Analysis
    1. 3.2.2.1 Bargaining Power of Suppliers
    2. 3.2.2.2 Bargaining Power of Buyers
    3. 3.2.2.3 Threat of New Entrants
    4. 3.2.2.4 Threat of Substitutes
    5. 3.2.2.5 Intensity of Rivalry
  3. 3.2.3 COVID-19 Impact Analysis
    1. 3.2.3.1 Market Impact Analysis
    2. 3.2.3.2 Regional Impact
    3. 3.2.3.3 Opportunity and Threat Analysis
4 SECTION IV: QUANTITATIVE ANALYSIS
1. 4.1 UK Morphine Market, BY Application (USD Billion)
  1. 4.1.1 Pain Management
  2. 4.1.2 Palliative Care
  3. 4.1.3 Anesthesia
  4. 4.1.4 Cough Suppression
2. 4.2 UK Morphine Market, BY Formulation (USD Billion)
  1. 4.2.1 Injectable
  2. 4.2.2 Oral
  3. 4.2.3 Transdermal
  4. 4.2.4 Sustained Release
3. 4.3 UK Morphine Market, BY Distribution Channel (USD Billion)
  1. 4.3.1 Hospital Pharmacies
  2. 4.3.2 Retail Pharmacies
  3. 4.3.3 Online Pharmacies
  4. 4.3.4 Specialty Pharmacies
4. 4.4 UK Morphine Market, BY End User (USD Billion)
  1. 4.4.1 Hospitals
  2. 4.4.2 Clinics
  3. 4.4.3 Home Care Settings
  4. 4.4.4 Research Institutions
5 SECTION V: COMPETITIVE ANALYSIS
1. 5.1 Competitive Landscape
  1. 5.1.1 Overview
  2. 5.1.2 Competitive Analysis
  3. 5.1.3 Market share Analysis
  4. 5.1.4 Major Growth Strategy in the UK Morphine Market
  5. 5.1.5 Competitive Benchmarking
  6. 5.1.6 Leading Players in Terms of Number of Developments in the UK Morphine Market
  7. 5.1.7 Key developments and growth strategies
    1. 5.1.7.1 New Product Launch/Service Deployment
    2. 5.1.7.2 Merger & Acquisitions
    3. 5.1.7.3 Joint Ventures
  8. 5.1.8 Major Players Financial Matrix
    1. 5.1.8.1 Sales and Operating Income
    2. 5.1.8.2 Major Players R&D Expenditure. 2023
2. 5.2 Company Profiles
  1. 5.2.1 Mundipharma (GB)
    1. 5.2.1.1 Financial Overview
    2. 5.2.1.2 Products Offered
    3. 5.2.1.3 Key Developments
    4. 5.2.1.4 SWOT Analysis
    5. 5.2.1.5 Key Strategies
  2. 5.2.2 Purdue Pharma (GB)
    1. 5.2.2.1 Financial Overview
    2. 5.2.2.2 Products Offered
    3. 5.2.2.3 Key Developments
    4. 5.2.2.4 SWOT Analysis
    5. 5.2.2.5 Key Strategies
  3. 5.2.3 Teva UK (GB)
    1. 5.2.3.1 Financial Overview
    2. 5.2.3.2 Products Offered
    3. 5.2.3.3 Key Developments
    4. 5.2.3.4 SWOT Analysis
    5. 5.2.3.5 Key Strategies
  4. 5.2.4 Napp Pharmaceuticals (GB)
    1. 5.2.4.1 Financial Overview
    2. 5.2.4.2 Products Offered
    3. 5.2.4.3 Key Developments
    4. 5.2.4.4 SWOT Analysis
    5. 5.2.4.5 Key Strategies
  5. 5.2.5 Boehringer Ingelheim (GB)
    1. 5.2.5.1 Financial Overview
    2. 5.2.5.2 Products Offered
    3. 5.2.5.3 Key Developments
    4. 5.2.5.4 SWOT Analysis
    5. 5.2.5.5 Key Strategies
  6. 5.2.6 AstraZeneca (GB)
    1. 5.2.6.1 Financial Overview
    2. 5.2.6.2 Products Offered
    3. 5.2.6.3 Key Developments
    4. 5.2.6.4 SWOT Analysis
    5. 5.2.6.5 Key Strategies
  7. 5.2.7 Sandoz (GB)
    1. 5.2.7.1 Financial Overview
    2. 5.2.7.2 Products Offered
    3. 5.2.7.3 Key Developments
    4. 5.2.7.4 SWOT Analysis
    5. 5.2.7.5 Key Strategies
  8. 5.2.8 AbbVie (GB)
    1. 5.2.8.1 Financial Overview
    2. 5.2.8.2 Products Offered
    3. 5.2.8.3 Key Developments
    4. 5.2.8.4 SWOT Analysis
    5. 5.2.8.5 Key Strategies
3. 5.3 Appendix
  1. 5.3.1 References
  2. 5.3.2 Related Reports
6 LIST OF FIGURES
1. 6.1 MARKET SYNOPSIS
2. 6.2 UK MARKET ANALYSIS BY APPLICATION
3. 6.3 UK MARKET ANALYSIS BY FORMULATION
4. 6.4 UK MARKET ANALYSIS BY DISTRIBUTION CHANNEL
5. 6.5 UK MARKET ANALYSIS BY END USER
6. 6.6 KEY BUYING CRITERIA OF UK MORPHINE MARKET
7. 6.7 RESEARCH PROCESS OF MRFR
8. 6.8 DRO ANALYSIS OF UK MORPHINE MARKET
9. 6.9 DRIVERS IMPACT ANALYSIS: UK MORPHINE MARKET
10. 6.10 RESTRAINTS IMPACT ANALYSIS: UK MORPHINE MARKET
11. 6.11 SUPPLY / VALUE CHAIN: UK MORPHINE MARKET
12. 6.12 UK MORPHINE MARKET, BY APPLICATION, 2024 (% SHARE)
13. 6.13 UK MORPHINE MARKET, BY APPLICATION, 2024 TO 2035 (USD Billion)
14. 6.14 UK MORPHINE MARKET, BY FORMULATION, 2024 (% SHARE)
15. 6.15 UK MORPHINE MARKET, BY FORMULATION, 2024 TO 2035 (USD Billion)
16. 6.16 UK MORPHINE MARKET, BY DISTRIBUTION CHANNEL, 2024 (% SHARE)
17. 6.17 UK MORPHINE MARKET, BY DISTRIBUTION CHANNEL, 2024 TO 2035 (USD Billion)
18. 6.18 UK MORPHINE MARKET, BY END USER, 2024 (% SHARE)
19. 6.19 UK MORPHINE MARKET, BY END USER, 2024 TO 2035 (USD Billion)
20. 6.20 BENCHMARKING OF MAJOR COMPETITORS
7 LIST OF TABLES
1. 7.1 LIST OF ASSUMPTIONS
7.1.1
1. 7.2 UK MARKET SIZE ESTIMATES; FORECAST
  1. 7.2.1 BY APPLICATION, 2026-2035 (USD Billion)
  2. 7.2.2 BY FORMULATION, 2026-2035 (USD Billion)
  3. 7.2.3 BY DISTRIBUTION CHANNEL, 2026-2035 (USD Billion)
  4. 7.2.4 BY END USER, 2026-2035 (USD Billion)
2. 7.3 PRODUCT LAUNCH/PRODUCT DEVELOPMENT/APPROVAL
7.3.1
1. 7.4 ACQUISITION/PARTNERSHIP
7.4.1

Certified Researchers

Customize Report

UK Morphine Market Segmentation

UK Morphine Market By Application (USD Billion, 2022-2035)

Pain Management
Palliative Care
Anesthesia
Cough Suppression

UK Morphine Market By Formulation (USD Billion, 2022-2035)

Injectable
Oral
Transdermal
Sustained Release

UK Morphine Market By Distribution Channel (USD Billion, 2022-2035)

Hospital Pharmacies
Retail Pharmacies
Online Pharmacies
Specialty Pharmacies

UK Morphine Market By End User (USD Billion, 2022-2035)

Hospitals
Clinics
Home Care Settings
Research Institutions

Customer Stories

“This is really good guys. Excellent work on a tight deadline. I will continue to use you going forward and recommend you to others. Nice job”

Noah Malgeri Co-Founder

“Thanks. It’s been a pleasure working with you, please use me as reference with any other Intel employees.”

Joseph Aguayo Sales Operations & Pricing Manager

“Thanks for sending the report it gives us a good global view of the Betaïne market.”

Peter Groot koerkamp Account and Business Manager

“Thank you, this will be very helpful for OQS.”

La Terria Dodd Program Support Specialist

“We found the report very insightful! we found your research firm very helpful. I'm sending this email to secure our future business.”

Younghwan Choi Senior Retail Manager

“I am very pleased with how market segments have been defined in a relevant way for my purposes (such as "Portable Freezers & refrigerators" and "last-mile"). In general the report is well structured. Thanks very much for your efforts.”

Mark Irwin Management Consultant

“I have been reading the first document or the study, ,the Global HVAC and FP market report 2021 till 2026. Must say, good info! I have not gone in depth at all parts, but got a good indication of the data inside!”